Loading...

SQZ Biotechnologies Company

SQZNYSE
Healthcare
Biotechnology
$0.43
$0.16(61.11%)

SQZ Biotechnologies Company (SQZ) Stock Overview

Explore SQZ Biotechnologies Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 60.2/100

Key Financials

Market Cap12.8M
P/E Ratio-0.16
EPS (TTM)$-2.16
ROE-0.86%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.05

SQZ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SQZ Biotechnologies Company (SQZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.05.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.16 and a market capitalization of 12.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;